ACS Chem Biol. 2018 Sep 21;13(9):2645-2654. doi: 10.1021/acschembio.8b00562. Epub 2018 Sep 11.
Matrix metalloproteases (MMPs) are a large family of zinc-dependent endopeptidases involved in a diverse set of physiological and pathological processes, most notably in cancer. Current methods for imaging and quantifying MMP activity lack sufficient selectivity and spatiotemporal resolution to allow studies of specific MMP function in vivo. Previously, we reported a strategy for selective targeting of MMPs by engineering a functionally silent cysteine mutation that enables highly specific covalent modification by a designed activity-based probe. Here, we describe the translation of that technology into a mouse model of breast cancer and subsequent demonstration of the utility of the approach for studies of MMP-14 activation in the tumor microenvironment. Using this approach, we find that MMP-14 is active in late stage tumors and is predominantly associated with stromal cell populations that have been activated by specific signaling molecules (e.g., TGFβ) produced by tumor cells. Our data demonstrate the applicability of this approach for studies of MMP function in whole organisms and identify important regulatory mechanisms for MMP-14 activity in the tumor microenvironment.
基质金属蛋白酶(MMPs)是一大类锌依赖性内肽酶,参与多种生理和病理过程,尤其是在癌症中。目前用于成像和定量 MMP 活性的方法缺乏足够的选择性和时空分辨率,无法在体内研究特定 MMP 功能。之前,我们通过工程化一种功能沉默的半胱氨酸突变来报告一种 MMP 选择性靶向的策略,该突变允许通过设计的活性基础探针进行高度特异性的共价修饰。在这里,我们将该技术转化为乳腺癌的小鼠模型,并随后证明该方法在研究肿瘤微环境中 MMP-14 激活中的应用。使用这种方法,我们发现 MMP-14 在晚期肿瘤中具有活性,并且主要与肿瘤细胞产生的特定信号分子(例如 TGFβ)激活的基质细胞群体相关。我们的数据证明了该方法在整个生物体中 MMP 功能研究中的适用性,并确定了肿瘤微环境中 MMP-14 活性的重要调节机制。